President, Co-Founder & Board Director, Thomas Forest Farb

Serial life sciences & technology entrepreneur at Cytyc, Indevus Pharmaceuticals, Interneuron Pharmaceuticals, MedicaMetrix & Trust for Science & Technology. (email

CSO, Co-Founder & Board Director, Alan Blanchard, Ph.D.

Numerous commercial instrumentation successes in DNA sequencing & DNA microarrays at Life Technologies, Applied Biosystems, Agencourt Personal Genomics & Rosetta Inpharmatics. B.S. & Ph.D., California Institute of Technology & postdoctoral fellowship with Lee Hood. Seven issued patents. (email

VP Engineering & Manufacturing, Brian Foley

Former Head of Technology & Engineering at Merck Millipore; numerous products developed & launched. Merck Innovation Award. Nine issued patents. (email

VP Market Development, Bruce Turner

Business development, marketing & management experience; Erie Scientific, Apogent Tech, MJ Research, Bridge Bio, BioInnovations & Thermo Fisher.  Eleven issued patents (email

General Counsel, Christian LaPointe, Ph.D., J.D.

General Counsel at ArcherDX, Enzymatics, Axios, Aramark. Senior Patent Manager, Dana Farber Cancer Institute, Testa Hurwitz & Thibeault. Ph.D., Dartmouth, Biochemistry. Two issued patents.

Outside Board of Directors

Guy Broadbent, Chairperson

CEO, Argotec; Previous: President, Thermo Fisher Scientific, Laboratory Products Group; CEO, XcellerX (acquired by GE); Member of Board of Directors at Sample6 Technologies, Blue Sky Biotech & Galius BioPharmaceuticals.

Michael Finney, Ph.D., Director

Managing Director, Finney Capital; Previous: Co-founder & CSO, MJ Research; CEO, Vaxart; Member of Board of Directors at Genome Partnership, Innerscope Research, Orion Genomics, Sage Science & Vaxart. Ph.D., Massachusetts Institute of Technology, Biology.

Brock C. Reeve, M.Phil, MBA, Director

Executive Director of Harvard Stem Cell Institute; Previous: Managing Director & COO of Life Science Insights, an IDC company;  Healthcare Practice Director of Viant Corp.; Principal of SRI Consulting.  M.Phil, Yale; MBA, Harvard Business School

Advisory Board

Stephen Fantone, Ph.D. (Optics)

  • Founder & CEO, Optikos Corporation
  • Director, American Optical Society
  • MIT, University of Rochester (Ph.D.)

Mariano Garcia-Blanco, M.D., Ph.D. (Biology)

  • Prof & Chair, Biochemistry & Molecular Biology, U of Texas Medical Branch
  • Prof, Duke-NUS Med School, Singapore
  • Yale (M.D. & Ph.D.)

Guy Fish, M.D., M.B.A. (Strategy & Market Research)

  • VP, Health Practices Group, Fletcher Spaght
  • VP, Business Development & International, Collagenesis
  • Yale (M.D., M.B.A.)

Anna Kushnir, Ph.D. (Government Grants / Policy)

  • VP, Life Sciences, Strategic Marketing Innovations
  • Harvard Medical School (Ph.D.)

James Kurnick, M.D. (Cancer, Drug Development)

  • President, Cytocure, Tribiotica
  • Harvard Medical School (M.D.)

Stan Lapidus (Diagnostics)

  • Founder & CEO of SynapDx, Helicos, Exact Labs, Cytyc
  • Cooper Union

Gaël McGill, Ph.D. (Cell Biology, Software)

  • Founder & CEO, Digizyme
  • Director of Molecular Visualization, Harvard Med
  • Swarthmore, Harvard Medical School (Ph.D.)

James Sherley, M.D., Ph.D. (Stem Cells)

  • Founder, Asymmetrex
  • Former Director, Adult Stem Cell Technology Center
  • Johns Hopkins Medical School (M.D., Ph.D.)

Jesus Soriano, M.D., Ph.D., MBA (Business Development)

  • Program Director, National Science Foundation
  • Head of Business Development: Osiris, ATCC & EntreMed
  • University of Geneva Med (M.D., Ph.D.), Johns Hopkins (M.B.A.)